Key facts
- U.S. officials are in secret talks with Germany over drug prices.
- The Trump administration believes American patients overpay for drugs.
- The U.S. seeks European contribution on drug pricing.
- House tax writers are preparing for a hearing on sports league taxation.
- The hearing may address potential new taxes on sports leagues.
- Lobbyists' influence on sports league taxation is a focus.
- Representative Jason Crow stated many administration officials use prediction markets.
- Crow's group aims to eliminate administration officials' use of prediction markets.
U.S. government representatives are engaged in confidential discussions with Germany concerning drug prices. The Trump administration's objective is to communicate that American patients are overpaying for medications and to seek a contribution from European nations in addressing this issue. The administration believes that European pricing standards should be considered in the U.S. context.
In parallel, House tax writers are reportedly preparing for a hearing focused on the taxation of sports leagues. This hearing is expected to cover a variety of potential issues related to sports league finances and taxation. A key aspect of the preparation involves examining the influence of lobbyists who may seek to shape the legislative outcomes concerning these potential new taxes.